Position in NTRA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$6,514
-$12,958 QoQ
Shares Held
24
-71.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#771
of 844 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Activest Wealth Management holds $194,602 across 18 Diagnostics & Research names. NTRA ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
291 | $55,429 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
220 | $49,893 | |
| 3 | ILMN |
Illumina, Inc.
|
154 | $27,077 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
113 | $21,833 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
24 | $12,710 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
15 | $7,520 | |
| 7 | NTRA |
Natera, Inc.
This page
|
24 | $6,514 | |
| 8 | A |
Agilent Technologies, Inc.
|
40 | $5,313 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,514 | 24 | Shares | Sole | 2026-07-16 | |
| 2025-12-31 | $19,472 | 85 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,219 | 20 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,365 | 14 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $15 | 0 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $33 | 0 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $126 | 1 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5 | 0 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5 | 0 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||